|Biotech Due Diligence||
Enjoy a collection of recent scientific and medical journal articles that have driven the news, conversation, and biotech stocks recently. As always, curated / crowd-sourced from the collective wisdom of the Twitterverse.
This week's Medical Device Reading List dives into recent updates from Medtronic as well as news regarding the impact of a recall from Stryker.
Medtronic's (MDT) CE Mark in Heart Lead Strengthens CVG Arm
Medtronic (MDT) Beats Q1 Earnings, Misses Revenue Estimates
Medtronic (MDT) Announces CE Mark for Attain Stability Quad MRI SureScan Active-Fixation Heart
Street Insider ($MDT)
Stryker Corp. stock drops 4% on voluntary recall, temporary ship hold and lowered 2017 earnings guidance
Emma Court, Market Watch ($SYK)
How Two Common Medications Became One $455 Million Specialty Pill
Marshall Allen (The Atlantic)
The Startling History Behind Merck's New Cancer Blockbuster
David Shaywitz (Forbes)
Conquering HIV’s capsid: After a dozen years, researchers have struck upon a molecule that can disrupt an elusive HIV target
Lisa Jarvis (Chemistry & Engineering News)
Birth of CRISPR’d pigs advances hopes for turning swine into organ donors
Sharon Begley (STAT News)
Opinionome: The past and future value of GWAS
Tom Ulrich (Broad Institute)
What’s Harder Than Making Copycat Biotech Drugs? Selling Them
Jared Hopkins (Bloomberg)
Did the CEO Actually Get Fired? There’s a Decoder for That
Vanessa Fuhrmans (Wall Street Journal)
This week's Medical Device Reading List dives into $ISRG with articles about revenue strategy, stock ownership, and a recently announced stock split. Also, $JNJ closes the door on acquisitions in the cardiology space and $ZBH must address a federal subpoena regarding compensation for physician consultants.
How Intuitive Surgical, Inc. Makes Most of Its Money
Keith Speights, Motley Fool ($ISRG)
Who Owns Most Of Intuitive Surgical Inc (ISRG)?
Thomas Auclair, Simply Wall St ($ISRG)
Intuitive Surgical plans stock split as shares near $1,000
Jeremy C. Owens, Market Watch ($ISRG)
Analyst: Johnson & Johnson tables cardiology M&A – for now
Brad Perriello, Mass Device ($JNJ)
Zimmer Biomet Holdings (ZBH) Received OIG Subpoena in June
Street Insider ($ZBH)
Growth ahead for $MDT, $JNJ, growth behind for $BSX!
Get the details in this week's Medical Device Reading List.
Boston Scientific Corporation (BSX) Issues Quarterly Earnings Results
Rex Bailey, Week Herald ($BSX)
Transcatheter Heart Valve Therapy: Growth Driver for Edwards Lifesciences
Margaret Patrick, Market Realist ($EW)
Medtronic Completes Sale of a Portion of Its Patient Monitoring & Recovery Division to Cardinal Health
Cardiovascular Business ($MDT)
Medtronic's Avalus valve OK'd in U.S. and Europe
Douglas W. House, Seeking Alpha ($MDT)
Johnson & Johnson Vision to acquire TearScience
Helio Ocular Surgery News ($JNJ)